Biodegradable Microspheres Loaded with an Anti-Parkinson Prodrug: An <i>in Vivo</i> Pharmacokinetic Study
Eleonora D’Aurizio(University of Chieti-Pescara), Antonio Di Stefano(University of Chieti-Pescara), Laura Serafina Cerasa(University of Chieti-Pescara), Wim E. Hennink(Utrecht University), Michèle Vacca(University of Cambridge), Annalisa Chiavaroli(University of Chieti-Pescara), Giustino Orlando(University of Chieti-Pescara), Piera Sozio(University of Chieti-Pescara), Luigi Brunetti(University of Chieti-Pescara), Robbert J. Kok(Utrecht University)
Cited by 38
Related Papers
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285